Thus, due to the accumulating evidence for a role of GSNOR in asthma pathogenesis [21], [23], [24], we investigated in the present study the effect of a selective inhibitor of GSNOR, SPL-334, on allergic airway inflammation. Here, ADH5 is linked to asthma.